Where does Vero Biotech Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Vero Biotech Inc. ranks #9,664 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Vero Biotech Inc. hold?

Vero Biotech Inc. holds 33 US utility patents granted between 2018 and 2025, spanning 12 technology areas.

What is Vero Biotech Inc.'s Innovation Score?

Vero Biotech Inc. has an Innovation Score of 43.6 out of 100 (top 28% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Vero Biotech Inc.'s patent grant rate increasing or decreasing?

Vero Biotech Inc.'s recent grant velocity is +420% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Vero Biotech Inc.'s patents?

Vero Biotech Inc.'s patents average 14.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Vero Biotech Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Vero Biotech Inc.

Q: What technology areas does Vero Biotech Inc. focus on?

Vero Biotech Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 28 patents. Grants appear in 12 CPC subclasses total.

USPTO PatentsView assignee record - 33 granted patents across 12 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Vero ranks #9,664 of 49,997 tracked US assignees by granted-patent volume, with 33 patents across 12 technology areas.

#9,664
of 49,997 US assignees by volume: Top 28%
by Innovation Score (43.6/100): 14.8
avg claims per patent: +420%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9664 · US Corporation #9,664 · 33 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 33 grants
UPPER-Q #9,664/49,997
PHOTO-FINISH Université de Nice…
CPC-FOCUS A61M · 12 areas
INNOV-PAR 43.6/100
CLAIMS-RICH 14.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +420% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Université de Nice Sophia-Antipolis (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Megagen Implant · near

44
Cornelius · near

44
Gtat · near

44
Vero Biotech · this assignee

44
Avedro · near

44
3D Lighting… · lowest

7

What this shows Vero's Innovation Score is 43.6/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Vero's grants concentrate

Vero Biotech Inc. is a focused PatentsView assignee: 12 CPC subclasses with 84.8% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2021 (7 grants) versus a trough of 2 in 2019. By volume, Vero sits between Université de Nice Sophia-Antipolis and Wako Pure Chemical Industries, Ltd..

Vero's three-year grant acceleration

Vero Biotech Inc. shows 17 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Université de Nic…

33
Vanguard Packaging

33
Varidesk

33
Vecna Robotics

33
Verona Holdings S…

33
Velano Vascular

33
Vidyo

33
Wako Pure Chemica…

33
Vero Biotech ◀

33

What this shows Vero holds 33 patents at rank #9,661, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Vero

By rank, the assignees closest to #9,661 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Vero's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Vero, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Gtat Corporation 44 Cornelius, Inc. 44 Megagen Implant Co., Ltd. 44 Avedro, Inc. 44

Vero's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 28% higher than 72% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Vero Biotech Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	3	9.1%
2019	2	6.1%
2020	2	6.1%
2021	7	21.2%
2022	5	15.2%
2023	7	21.2%
2024	5	15.2%
2025partial year	2	6.1%

Which technologies does Vero Biotech Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 28

C01B - Non-metallic ELEMENTS; Compounds THEREOF; ; Metalloids OR Compounds Thereof NOT Covered BY Subclass C01c 23

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 15

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 13

A61D - Veterinary Instruments, Implements, Tools, OR Methods 8

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 7

A62B - Devices, Apparatus OR Methods FOR Life-saving 6

Y02A - Technologies FOR Adaptation TO Climate Change 5

Y10T - Technical Subjects Covered BY Former US Classification 4

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 3

B01D - Separation 2

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 12 of 12 technology areas

Where it ranks

Overall rank by patents

#9,664

of 49,997 tracked assignees

Innovation Score

43.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Vero Biotech Inc.'s patent record in context - here's where to go next.

Vero Biotech Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 84.8% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #9,664 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Vero Biotech Inc. against Université de Nice Sophia-Antipolis, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.